{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T22:29:39Z","timestamp":1785796179629,"version":"3.56.0"},"reference-count":35,"publisher":"Wiley","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":546,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Neurol Scand"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1111\/ane.12233","type":"journal-article","created":{"date-parts":[[2014,3,4]],"date-time":"2014-03-04T07:11:53Z","timestamp":1393917113000},"page":"26-31","source":"Crossref","is-referenced-by-count":77,"special_numbering":"supplement s198","title":["Myasthenia gravis epidemiology in a national cohort; combining multiple disease registries"],"prefix":"10.1155","volume":"129","author":[{"given":"J. B.","family":"Andersen","sequence":"first","affiliation":[{"name":"Department of Clinical Medicine; University of Bergen; Bergen Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. T.","family":"Heldal","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine; University of Bergen; Bergen Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Engeland","sequence":"additional","affiliation":[{"name":"Division for Epidemiology; Department of Pharmacoepidemiology; Norwegian Institute of Public Health; Bergen Norway"},{"name":"Department of Global Public Health and Primary Care; University of Bergen; Bergen Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. E.","family":"Gilhus","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine; University of Bergen; Bergen Norway"},{"name":"Department of Neurology; Haukeland University Hospital; Bergen Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2014,3,4]]},"reference":[{"key":"10.1111\/ane.12233-BIB0001|ane12233-cit-0001","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/WCO.0b013e3283572588","article-title":"Myasthenia and the neuromuscular junction","volume":"25","author":"Gilhus","year":"2012","journal-title":"Curr Opin Neurol"},{"key":"10.1111\/ane.12233-BIB0002|ane12233-cit-0002","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1586\/eci.12.34","article-title":"Muscle autoantibodies in myasthenia gravis: beyond diagnosis?","volume":"8","author":"Meriggioli","year":"2012","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1111\/ane.12233-BIB0003|ane12233-cit-0003","first-page":"33","article-title":"Antibody specificity in myasthenia gravis","volume":"25","author":"Vincent","year":"1988","journal-title":"Monogr Allergy"},{"key":"10.1111\/ane.12233-BIB0004|ane12233-cit-0004","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1600-0404.2006.00609.x","article-title":"Myasthenia gravis: disease severity and prognosis","volume":"183","author":"Romi","year":"2006","journal-title":"Acta Neurol Scand Suppl"},{"key":"10.1111\/ane.12233-BIB0005|ane12233-cit-0005","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1600-0404.2006.00606.x","article-title":"Clinical aspects of neuromuscular transmission disorders","volume":"183","author":"Evoli","year":"2006","journal-title":"Acta Neurol Scand Suppl"},{"key":"10.1111\/ane.12233-BIB0006|ane12233-cit-0006","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.autrev.2013.03.002","article-title":"Serological diagnostics in myasthenia gravis based on novel assays and recently identified antigens","volume":"12","author":"Zisimopoulou","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1111\/ane.12233-BIB0007|ane12233-cit-0007","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3109\/08916930903541208","article-title":"Diagnostic use of autoantibodies in myasthenia gravis","volume":"43","author":"Leite","year":"2010","journal-title":"Autoimmunity"},{"key":"10.1111\/ane.12233-BIB0008|ane12233-cit-0008","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3109\/08916930903555943","article-title":"Antibody effector mechanisms in myasthenia gravis-pathogenesis at the neuromuscular junction","volume":"43","author":"Gomez","year":"2010","journal-title":"Autoimmunity"},{"key":"10.1111\/ane.12233-BIB0009|ane12233-cit-0009","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1471-2377-10-46","article-title":"A systematic review of population based epidemiological studies in Myasthenia Gravis","volume":"10","author":"Carr","year":"2010","journal-title":"BMC Neurol"},{"key":"10.1111\/ane.12233-BIB0010|ane12233-cit-0010","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1159\/000279334","article-title":"The incidence of myasthenia gravis: a systematic literature review","volume":"34","author":"McGrogan","year":"2010","journal-title":"Neuroepidemiology"},{"key":"10.1111\/ane.12233-BIB0011|ane12233-cit-0011","first-page":"129","article-title":"Establishment of the nationwide Norwegian Prescription Database (NorPD) - new opportunities for research in pharmacoepidemiology in Norway","volume":"18","author":"Furu","year":"2008","journal-title":"Nor J Epidemiol"},{"key":"10.1111\/ane.12233-BIB0012|ane12233-cit-0012","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1742-7843.2009.00494.x","article-title":"The Nordic countries as a cohort for pharmacoepidemiological research","volume":"106","author":"Furu","year":"2010","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1111\/ane.12233-BIB0013|ane12233-cit-0013","unstructured":"The Research Council of Norway Evaluation of biology, medicine and health research in Norway Oslo 2011"},{"key":"10.1111\/ane.12233-BIB0014|ane12233-cit-0014","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1212\/WNL.0b013e3181ad53c2","article-title":"Seropositive myasthenia gravis: a nationwide epidemiologic study","volume":"73","author":"Heldal","year":"2009","journal-title":"Neurology"},{"key":"10.1111\/ane.12233-BIB0015|ane12233-cit-0015","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1002\/mus.23271","article-title":"Geographical distribution of a seropositive myasthenia gravis population","volume":"45","author":"Heldal","year":"2012","journal-title":"Muscle Nerve"},{"key":"10.1111\/ane.12233-BIB0016|ane12233-cit-0016","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1111\/j.1468-1331.2010.03089.x","article-title":"Myasthenia gravis requiring pyridostigmine treatment in a national population cohort","volume":"17","author":"Andersen","year":"2010","journal-title":"Eur J Neurol"},{"key":"10.1111\/ane.12233-BIB0017|ane12233-cit-0017","doi-asserted-by":"crossref","first-page":"e8497","DOI":"10.1136\/bmj.e8497","article-title":"Myasthenia gravis","volume":"345","author":"Spillane","year":"2012","journal-title":"BMJ"},{"key":"10.1111\/ane.12233-BIB0018|ane12233-cit-0018","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.1468-1331.2006.01476.x","article-title":"Guidelines for the treatment of autoimmune neuromuscular transmission disorders","volume":"13","author":"Skeie","year":"2006","journal-title":"Eur J Neurol"},{"key":"10.1111\/ane.12233-BIB0019|ane12233-cit-0019","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1136\/jnnp.2009.193912","article-title":"Myasthenia gravis and other neuromuscular junction disorders","volume":"9","author":"Jacob","year":"2009","journal-title":"Pract Neurol"},{"key":"10.1111\/ane.12233-BIB0020|ane12233-cit-0020","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1111\/j.1468-1331.2012.03698.x","article-title":"A national epidemiological study of Myasthenia Gravis in Australia","volume":"19","author":"Gattellari","year":"2012","journal-title":"Eur J Neurol"},{"key":"10.1111\/ane.12233-BIB0021|ane12233-cit-0021","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1159\/000331481","article-title":"Identifying patients with myasthenia for epidemiological research by linkage of automated registers","volume":"37","author":"Pedersen","year":"2011","journal-title":"Neuroepidemiology"},{"key":"10.1111\/ane.12233-BIB0022|ane12233-cit-0022","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0165-5728(94)90129-5","article-title":"Anti-acetylcholine receptor (AChR) antibodies measurement in myasthenia gravis: the use of cell line TE671 as a source of AChR antigen","volume":"51","author":"Somnier","year":"1994","journal-title":"J Neuroimmunol"},{"key":"10.1111\/ane.12233-BIB0023|ane12233-cit-0023","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1136\/jnnp.41.5.394","article-title":"Determination of acetylcholine receptor antibody in myasthenia gravis: clinical usefulness and pathogenetic implications","volume":"41","author":"Lefvert","year":"1978","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1111\/ane.12233-BIB0024|ane12233-cit-0024","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1046\/j.1468-1331.2003.00678.x","article-title":"Disease severity and outcome in thymoma myasthenia gravis: a long-term observation study","volume":"10","author":"Romi","year":"2003","journal-title":"Eur J Neurol"},{"key":"10.1111\/ane.12233-BIB0025|ane12233-cit-0025","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1196\/annals.1405.020","article-title":"Myasthenia gravis seronegative for acetylcholine receptor antibodies","volume":"1132","author":"Vincent","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"10.1111\/ane.12233-BIB0026|ane12233-cit-0026","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1093\/clinchem\/43.5.824","article-title":"Modified and improved anti-acetylcholine receptor (AchR) antibody assay: comparison of analytical and clinical performance with conventional anti-AChR antibody assay","volume":"43","author":"Ferrero","year":"1997","journal-title":"Clin Chem"},{"key":"10.1111\/ane.12233-BIB0027|ane12233-cit-0027","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1159\/000311012","article-title":"Nationwide population-based epidemiological study of myasthenia gravis in taiwan","volume":"35","author":"Lai","year":"2010","journal-title":"Neuroepidemiology"},{"key":"10.1111\/ane.12233-BIB0028|ane12233-cit-0028","doi-asserted-by":"crossref","first-page":"A383","DOI":"10.1016\/j.autrev.2009.11.011","article-title":"Geoepidemiology of myasthenia gravis [corrected]","volume":"9","author":"Meyer","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1111\/ane.12233-BIB0029|ane12233-cit-0029","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1586\/14737175.9.3.351","article-title":"Autoimmune myasthenia gravis","volume":"9","author":"Gilhus","year":"2009","journal-title":"Expert Rev Neurother"},{"key":"10.1111\/ane.12233-BIB0030|ane12233-cit-0030","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1196\/annals.1254.054","article-title":"Myasthenia gravis (MG): epidemiological data and prognostic factors","volume":"998","author":"Mantegazza","year":"2003","journal-title":"Ann N Y Acad Sci"},{"key":"10.1111\/ane.12233-BIB0031|ane12233-cit-0031","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1196\/annals.1405.040","article-title":"Myasthenia gravis in the elderly: is it different?","volume":"1132","author":"Aarli","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"10.1111\/ane.12233-BIB0032|ane12233-cit-0032","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1111\/j.1468-1331.2010.03017.x","article-title":"Course and prognosis of myasthenia gravis: a systematic review","volume":"17","author":"Mao","year":"2010","journal-title":"Eur J Neurol"},{"key":"10.1111\/ane.12233-BIB0033|ane12233-cit-0033","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1001\/archneur.1991.00530190081019","article-title":"Epidemiology of myasthenia gravis in Denmark. A longitudinal and comprehensive population survey","volume":"48","author":"Somnier","year":"1991","journal-title":"Arch Neurol"},{"key":"10.1111\/ane.12233-BIB0034|ane12233-cit-0034","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1600-0404.1989.tb03793.x","article-title":"Epidemiological study of myasthenia gravis in Sardinia, Italy (1958-1986)","volume":"79","author":"Giagheddu","year":"1989","journal-title":"Acta Neurol Scand"},{"key":"10.1111\/ane.12233-BIB0035|ane12233-cit-0035","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1468-1331.2006.01538.x","article-title":"Myasthenia gravis in pregnancy and birth: identifying risk factors, optimising care","volume":"14","author":"Hoff","year":"2007","journal-title":"Eur J Neurol"}],"container-title":["Acta Neurologica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fane.12233","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/ane.12233\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T12:47:17Z","timestamp":1671540437000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ane.12233"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,4]]},"references-count":35,"URL":"https:\/\/doi.org\/10.1111\/ane.12233","relation":{},"ISSN":["0001-6314"],"issn-type":[{"value":"0001-6314","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3,4]]}}}